Geographically, global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
AstraZenenca
Astellas Pharmaceuticals
Salix Pharmaceuticals Ltd
GlaxoSmithKline
Actavis
Pfizer
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs for each application, including
Hospitals
Clinics
Others
Production, consumption, revenue, market share and growth rate are the key targets for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
2.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
3.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
4 Competitive Analysis
4.1 AstraZenenca
4.1.1 AstraZenenca Profiles
4.1.2 AstraZenenca Product Information
4.1.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin
4.1.4 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance
4.1.5 SWOT Analysis
4.2 Astellas Pharmaceuticals
4.2.1 Astellas Pharmaceuticals Profiles
4.2.2 Astellas Pharmaceuticals Product Information
4.2.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin
4.2.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance
4.2.5 SWOT Analysis
4.3 Salix Pharmaceuticals Ltd
4.3.1 Salix Pharmaceuticals Ltd Profiles
4.3.2 Salix Pharmaceuticals Ltd Product Information
4.3.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin
4.3.4 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance
4.3.5 SWOT Analysis
4.4 GlaxoSmithKline
4.4.1 GlaxoSmithKline Profiles
4.4.2 GlaxoSmithKline Product Information
4.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin
4.4.4 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance
4.4.5 SWOT Analysis
4.5 Actavis
4.5.1 Actavis Profiles
4.5.2 Actavis Product Information
4.5.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin
4.5.4 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance
4.5.5 SWOT Analysis
4.6 Pfizer
4.6.1 Pfizer Profiles
4.6.2 Pfizer Product Information
4.6.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin
4.6.4 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance
4.6.5 SWOT Analysis
5 Competitive Landscape
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Assessment by Regions
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Regions (2014-2020)
6.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Gross Margin by Regions (2014-2020)
7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Regional Analysis
7.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.2 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
7.8 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate (2014-2020)
8 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Assessment
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Market Share by Regions (2014-2020)
8.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) by Regions (2014-2020)
9 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Assessment by Regions
9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
9.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2021-2026
12.1 Production and Revenue Forecast 2021-2026
12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Revenue by Regions 2021-2026
12.1.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.1.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate 2021-2026
12.2 Sales and Sales Value Forecast 2021-2026
12.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Consumption Calue by Regions 2021-2026
12.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2021-2026
12.2.4 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.7 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.8 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.9 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.2.10 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Sales Value Forecast 2021-2026
12.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Revenue Forecast by Type 2021-2026
12.3.1 Overall Market Performance
12.3.2 Preface
12.3.3 Eluxadoline
12.3.4 Alosetron
12.3.5 Rifaximin
12.3.6 Loperamide
12.3.7 Diphenoxylate + Atropine
12.3.8 Dicyclomine and Hyoscyamine
12.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 Hospitals
12.4.3 Clinics
12.4.4 Others
12.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Gross Margin Forecast
13.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Averages Price Development Trend Forecast 2021-2026
13.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Gross Margin Development Trend Forecast 2021-2026
13 Conclusion